David B. Hunninghake, MD
Advertisement
Articles by David B. Hunninghake, MD
Advertisement
Latest Updated Articles
- Review of the NIH Post-CABG Study and Future Advances in HMG-CoA Therapy
Published: March 1st 1997 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5
